HEALTH IN TECH INC-CLASS A (HIT) Forecast, Price Target & Analyst Ratings

NASDAQ:HIT • US42217D1028

Current stock price

1.37 USD
+0.03 (+2.24%)
At close:
1.35 USD
-0.02 (-1.46%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HEALTH IN TECH INC-CLASS A (HIT).

Forecast Snapshot

Consensus Price Target

Price Target
$4.34
+ 216.42% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 20, 2026
Period
Q1 / 2026
EPS Estimate
-$0.03
Revenue Estimate
7.413M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$4.34
Upside
+ 216.42%
From current price of $1.37 to mean target of $4.34, Based on 5 analyst forecasts
Low
$4.04
Median
$4.34
High
$4.73

Price Target Revisions

1 Month
-5.56%
3 Months
-5.56%

Price Target Summary

5 Wall Street analysts provided a forecast for the next 12 months for HIT. The average price target is 4.34 USD. This implies a price increase of 216.42% is expected in the next year compared to the current price of 1.37.
The average price target has been revised downward by 5.56% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

HIT Current Analyst RatingHIT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

HIT Historical Analyst RatingsHIT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -9 -8 -7 -6 -5 -4 -3 -2 -1 0 1 2 3 4

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
HIT was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about HIT.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed HIT. So this is just the average opinion of a couple of analysts.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-06-26Maxim GroupInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 20, 2026
Period
Q1 / 2026
EPS Estimate
-$0.03
Revenue Estimate
7.413M
Revenue Q2Q
-7.57%
EPS Q2Q
-403.00%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
-20.30%
Revenue (3 Months)
-20.30%
EPS (1 Month)
-200.00%
EPS (3 Months)
N/A

Next Earnings Summary

HIT is expected to report earnings on 4/20/2026. The consensus EPS estimate for the next earnings is -0.03 USD and the consensus revenue estimate is 7.41M USD.
The next earnings revenue estimate has been revised downward by 20.3% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027
Revenue
YoY % growth
HIT revenue by date.HIT revenue by date.
19.152M
231.93%		19.491M
1.77%		33.328M
70.99%		44.238M
32.74%		80.924M
82.93%
EBITDA
YoY % growth
HIT ebitda by date.HIT ebitda by date.
3.722M
1,710.51%		1.531M
-58.87%		2.429M
58.65%		2.51M
3.33%		17.191M
584.90%
EBIT
YoY % growth
HIT ebit by date.HIT ebit by date.
3.383M
1,545.48%		989.9K
-70.74%		1.528M
54.40%		102.01K
-93.33%		14.239M
13,858.44%
Operating Margin
HIT operating margin by date.HIT operating margin by date.
17.66%5.08%4.59%0.23%17.60%
EPS
YoY % growth
HIT eps by date.HIT eps by date.
N/AN/A0.02-0.01
-125.25%		0.17
3,500.00%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.03
-403.00%		-0.03
-352.50%		0.02
51.50%		0.04
453.50%		0.05
266.67%		0.04
260.00%		0.04
166.67%		0.05
42.86%
Revenue
Q2Q % growth		7.413M
-7.57%		7.265M
-22.00%		11.406M
34.35%		21.042M
180.26%		20.267M
173.40%		19.254M
165.02%		19.254M
68.81%		22.141M
5.22%
EBITDA
Q2Q % growth		-1.053M
-270.82%		-456.52K
-145.78%		653.47K
-33.56%		3.365M
361.09%		4.943M
569.23%		3.948M
964.80%		3.596M
450.29%		4.723M
40.36%
EBIT
Q2Q % growth		-1.664M
-446.26%		-1.063M
-246.53%		52.52K
-89.36%		2.774M
1,724.12%		4.201M
352.39%		3.206M
401.74%		2.853M
5,332.22%		3.98M
43.48%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

HIT Yearly Revenue VS EstimatesHIT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
HIT Yearly EPS VS EstimatesHIT Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 0.05 0.1 0.15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

HEALTH IN TECH INC-CLASS A / HIT Forecast FAQ

What is the average price target for HEALTH IN TECH INC-CLASS A (HIT) stock?

5 analysts have analysed HIT and the average price target is 4.34 USD. This implies a price increase of 216.42% is expected in the next year compared to the current price of 1.37.

When does HEALTH IN TECH INC-CLASS A (HIT) report earnings?

HEALTH IN TECH INC-CLASS A (HIT) will report earnings on 2026-04-20.

Can you provide the consensus estimates for HEALTH IN TECH INC-CLASS A next earnings?

The consensus EPS estimate for the next earnings of HEALTH IN TECH INC-CLASS A (HIT) is -0.03 USD and the consensus revenue estimate is 7.41M USD.